Law Zhe Kang, England Timothy J, Mistri Amit K, Woodhouse Lisa J, Cala Lesley, Dineen Rob, Ozturk Serefnur, Beridze Maia, Collins Ronan, Bath Philip M, Sprigg Nikola
Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
Department of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.
Eur Stroke J. 2020 Jun;5(2):123-129. doi: 10.1177/2396987320901391. Epub 2020 Jan 24.
Seizures are common after intracerebral haemorrhage. Tranexamic acid increases the risk of seizures in non-intracerebral haemorrhage population but its effect on post-intracerebral haemorrhage seizures is unknown. We explored the risk factors and outcomes of seizures after intracerebral haemorrhage and if tranexamic acid increased the risk of seizures in the Tranexamic acid for IntraCerebral Haemorrhage-2 trial.
Seizures were reported prospectively up to day 90. Cox regression analyses were used to determine the predictors of seizures within 90 days and early seizures (≤7 days). We explored the effect of early seizures on day 90 outcomes.
Of 2325 patients recruited, 193 (8.3%) had seizures including 163 (84.5%) early seizures and 30 (15.5%) late seizures (>7 days). Younger age (adjusted hazard ratio (aHR) 0.98 per year increase, 95% confidence interval (CI) 0.97-0.99; = 0.008), lobar haematoma (aHR 5.84, 95%CI 3.58-9.52; < 0.001), higher National Institute of Health Stroke Scale (aHR 1.03, 95%CI 1.01-1.06; = 0.014) and previous stroke (aHR 1.66, 95%CI 1.11-2.47; = 0.013) were associated with early seizures. Tranexamic acid did not increase the risk of seizure within 90 days. Early seizures were associated with worse modified Rankin Scale (adjusted odds ratio (aOR) 1.79, 95%CI 1.12-2.86, = 0.015) and increased risk of death (aOR 3.26, 95%CI 1.98-5.39; < 0.001) at day 90. Lobar haematoma was the strongest independent predictor of early seizures after intracerebral haemorrhage. Tranexamic acid did not increase the risk of post-intracerebral haemorrhage seizures in the first 90 days. Early seizures resulted in worse functional outcome and increased risk of death.
脑出血后癫痫发作很常见。氨甲环酸会增加非脑出血人群癫痫发作的风险,但其对脑出血后癫痫发作的影响尚不清楚。我们在脑出血-2氨甲环酸试验中探讨了脑出血后癫痫发作的危险因素和预后情况,以及氨甲环酸是否会增加癫痫发作的风险。
前瞻性记录至第90天的癫痫发作情况。采用Cox回归分析确定90天内癫痫发作和早期癫痫发作(≤7天)的预测因素。我们探讨了早期癫痫发作对第90天预后的影响。
在招募的2325例患者中,193例(8.3%)发生癫痫发作,其中163例(84.5%)为早期癫痫发作,30例(15.5%)为晚期癫痫发作(>7天)。年龄较小(校正风险比[aHR]为每年增加0.98,95%置信区间[CI]为0.97 - 0.99;P = 0.008)、脑叶血肿(aHR为5.84,95%CI为3.58 - 9.52;P < 0.001)、较高的美国国立卫生研究院卒中量表评分(aHR为1.03,95%CI为1.01 - 1.06;P = 0.014)和既往卒中(aHR为1.66,95%CI为1.11 - 2.47;P = 0.013)与早期癫痫发作相关。氨甲环酸并未增加90天内癫痫发作的风险。早期癫痫发作与第90天改良Rankin量表评分较差(校正比值比[aOR]为1.79,95%CI为1.12 - 2.86,P = 0.015)和死亡风险增加(aOR为3.26,95%CI为1.98 - 5.39;P < 0.001)相关。脑叶血肿是脑出血后早期癫痫发作最强的独立预测因素。氨甲环酸在最初90天内并未增加脑出血后癫痫发作的风险。早期癫痫发作导致功能预后较差且死亡风险增加。